Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer
- 1 January 2004
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 14 (1) , 42-50
- https://doi.org/10.1111/j.1048-891x.2004.14065.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?Gynecologic Oncology, 2002
- Preoperative CA‐125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancerActa Obstetricia et Gynecologica Scandinavica, 2001
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- Long-Term Survival in Advanced Ovarian Cancer after Cytoreduction and Chemotherapy TreatmentGynecologic Oncology, 1994
- Neoadjuvant Chemotherapy for Advanced Ovarian CancerGynecologic Oncology, 1994
- Reasons for incomplete surgical staging in early ovarian carcinomaGynecologic Oncology, 1990
- Secondary cytoreductive surgery in epithelial ovarian cancer: Nonresponders to first-line therapyGynecologic Oncology, 1989
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986
- Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinomaGynecologic Oncology, 1985
- An analysis of variance test for normality (complete samples)Biometrika, 1965